The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Velocity recently hosted its first virtual Velocity Fund Pitch Competition, investing a total of $250,000 in four early-stage tech startups.
The direct-to-consumer health insurer Oscar has raised another $225 million in its latest, late-stage round of funding as its vision of tech-enabled healthcare services to drive down consumer costs becomes more and more of a reality.
COVID-19 has pushed ahead virtual solutions to improve health care in rural and remote communities (CBC)
We have an opportunity to use the expansion of virtual health care resulting from COVID-19 to improve accessibility for people living in rural and remote areas of Saskatchewan.
With the US turning away talent, can Canada grab the global lead on innovation during COVID-19? (BETAKIT)
Shafin Diamond Tejani, founder and CEO of Victory Square Technologies, shares his thoughts on how Canada can capitalize on the new normal ushered in by COVID.
Airvet, a telehealth veterinary platform, just clawed its way to a $14 million Series A round (TECHCRUNCH)
With a pet in roughly 65% of U.S. homes, there is now a dizzying number of companies enabling vets to meet with their furry patients remotely.
Halifax-based healthtech startup Adaptiiv Medical Technologies won Atlantic Canada’s first Health Challenge Pitch Event, which focused on cancer care.
Canadian developer of “smartbomb for cancer” Fusion fails to ignite in Nasdaq debut (THE GLOBE AND MAIL)
A Hamilton startup hoping to transform how people are treated for cancer by injecting them with tiny nuclear smartbombs got stuck in no man’s land Friday on its first day as a public company.
Montréal-based health tech startup Carebook has partnered with Rexall to provide its free digital pharmacy platform to Rexall shoppers across Canada.
Deep01’s product has obtained clearance from both Taiwan and the United States’ Food and Drug Administrations, and the company received its first purchase order, worth about $700,000, in February.
Cyclica, a biotech company that has developed a drug discovery platform using artificial intelligence, has raised $23 million CAD in Series B financing.